Delivery Order SPE2DB22D3016-SPE2DB24FAYD4
- Not listed
- This federal contract award, valued at $13,463.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is March 24, 2025. The contract covers the procurement of DIGIFAB 40 MG VIALS, a pharmaceutical product, to support federal healthcare programs, particularly within military and veterans'...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $60,291.96 firm fixed-price delivery order contract is for the supply of DIGIFAB 40 MG VIALS medical products. The contract has an ultimate completion date of February 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award, with an ID of SPE2DB20D3101|SPE2DB25FQXU1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order valued at $15,083.90, is for the supply of 4566790385 ! DIGIFAB 40 MG VIALS. The contract has a firm fixed price and an ultimate completion date of December 24, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,738,224 units of the pharmaceutical product DIGIFAB 40 MG VIALS. The contract has a potential value of $37,013.12 and a completion date of February 23, 2024. This delivery order is issued under a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $15,064.55 to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of DIGIFAB 40 MG VIALS. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products...
- The Defense Logistics Agency awarded a $9,588.87 delivery order to AmerisourceBergen Drug Corp for 40 mg Digifab vials on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is performed at the contractor's location in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a delivery order valued at $5,707.24 to AmerisourceBergen Drug Corp for 40 mg Digifab vials, with an ultimate completion date of December 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, valued at $44,898.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for the DLA to procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
- This federal contract award, valued at $156,868.14, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that is Firm Fixed Price, with a performance period through December 22, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $807,318.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order contract is for a firm fixed price with an ultimate completion date of January 16, 2025. The contract is not set aside and allows for the provision of a wide range of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FAYD4Delivery Order
This federal contract award, valued at $48,918.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of DIGIFAB 40 MG VIALS, with a completion date of June 12, 2024. The contract type is Firm Fixed Price. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $48.9k | 6/11/24 |